3-aminopyridine-2-carboxaldehyde-thiosemicarbazone has been researched along with Hemolysis* in 3 studies
3 other study(ies) available for 3-aminopyridine-2-carboxaldehyde-thiosemicarbazone and Hemolysis
| Article | Year |
|---|---|
Rediscovery of the susceptibility of G6PD deficient persons to methemoglobinemia from oxidant drugs, and to hemolysis from methylene blue.
Topics: Enzyme Inhibitors; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Methylene Blue; Middle Aged; Pyridines; Thiosemicarbazones | 2007 |
Recognition and management of methemoglobinemia and hemolysis in a G6PD-deficient patient on experimental anticancer drug Triapine.
We report occurrence of severe methemoglobinemia in a patient on novel experimental anti-cancer drug, Triapine. Treatment with methylene blue led to massive hemolysis due to concomitant G6PD deficiency. We recommend that G6PD screening be done in high-risk populations prior to commencement of Triapine therapy. Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Methemoglobinemia; Middle Aged; Pyridines; Thiosemicarbazones | 2006 |
Drug-induced haemolysis and methaemoglobinaemia in glucose 6-phosphate dehydrogenase deficiency.
Topics: Antineoplastic Agents; Glucosephosphate Dehydrogenase Deficiency; Hemolysis; Humans; Male; Methemoglobinemia; Middle Aged; Pyridines; Thiosemicarbazones | 2005 |